Cytoadherence of Plasmodium falciparum-infected erythrocytes is mediated by a redox-dependent conformational fraction of CD36

Journal of Immunology

Volumn 167, Issue 11, 2001, Pages 6510-6517

  Gruarin, P ^a   Primo, L ^a   Ferrandi, C ^a   Bussolino, F ^a   Tandon, N N ^a   Arese, P ^a   Ulliers, D ^a   Alessio, M ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CD36 ANTIGEN; CELL SURFACE RECEPTOR; CYSTEINE; DITHIOTHREITOL; EPITOPE; MONOCLONAL ANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN; REDUCING AGENT;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ERYTHROCYTE ADHESIVENESS; HUMAN; HUMAN CELL; INFECTION COMPLICATION; MALARIA; MOLECULAR INTERACTION; NONHUMAN; OXIDATION REDUCTION REACTION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN CONFORMATION; VASCULAR ENDOTHELIUM; VENULE;

EID: 0035576215     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.11.6510     Document Type: Article

References (55)

1. Molecular mechanisms of cytoadherence in malaria
2. Identification of a region of PfEMPI that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: Conserved function with variant sequence
3. Cloning the P. falciparum gene encoding PfEMPI, a malarial variant antigen and adherence receptor on the surface of parasitized human erythrocytes
4. Falciparum malaria: Sticking up, standing out and out-standing
5. Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow
6. CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes
7. Rapid switching to multiple antigenic and adhesive phenotypes in malaria
8. Targeted gene disruption shows that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress
9. Identification of a platelet membrane glycoprotein as a falciparum malaria sequestration receptor
10. Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction, and transfusion medicine
11. Platelet activation and inhibition of malarial cytoadherence by the anti-CD36 lgM monoclonal antibody NL07
12. Analysis of CD36 binding domains: Ligand specificity controlled by dephosphorylation of an ectodomain
13. CD36 peptides that block cytoadherence define the CD36 binding region for Plasmodium falciparum-infected erythrocytes
14. Visualization of Plasmodium falciparum-endothelium interactions in human micro-vasculature: Mimicry of leukocyte recruitment
15. CD36 folding revealed by conformational epitope expression is essential for cytoadherence of Plasmodium falciparum-infected red blood cells
16. CD36 is a ditopic glycoprotein with the N-terminal domain implicated in intracellular transport
17. Formation of one or more intrachain disulphide bonds is required for the intracellular processing and transport of CD36
18. Plasmodium falciparum-infected erythrocytes and oxidized low-density lipoprotein bind to separate domains of CD36
19. Analysis of the human CD36 leucocyte differentiation antigen by means of the monoclonal antibody NL07
20. Isolation and characterization of platelet glycoprotein IV (CD36)
21. Antigenic and functional differences in adhesion of Plasmodium falciparum-infected erythrocytes to human and bovine CD36
22. Synthesis, processing, and intracellular transport of CD36 during monocytic differentiation
23. Advanced mammalian gene transfer: High titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line
24. Production of high-titer helper-free retroviruses by transient transfection
25. Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria
26. Synchronization of Plasmodium falciparum erythrocytic stages in culture
27. Phagocytosis of the malarial pigment, hemozoin, impairs expression of major histocompatibility complex class II antigen CD54, and CD1lc in human monocytes
28. A luminescence method for quantitative determination of phagocytosis of erythrocytes, of malaria-parasitized erythrocytes and malaria pigment
29. Methionine 156 in the immunodominant domain of CD36 contributes to define the epitope recognized by the NL07 MoAb
30. CD36 mediates the in vitro inhibitory effects of thrombospondin-I on endothelial cells
31. The Plasmodium falciparum-CD36 interaction is modified by a single amino acid substitution in CD36
32. CD36 forms covalently associated dimers and multimers in platelets and transfected COS-7 cells
33. Thrombospondin induces dimerization of membrane-bound, but not soluble CD36
34. Characterization of caveolinrich membrane domains isolated from an endothelial-rich source: Implications for human disease
35. Biochemical isolation of a membrane microdomain from resting platelets highly enriched in the plasma membrane glycoprotein Cd36
36. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain
37. Identification of a region of PfEMPI that mediates adherence of Plasmodium falciparum infected erythrocytes to CD36: Conserved function with variant sequence
38. The differential effects of dithiothreitol and 2-mercaptoethanol on the secretion of partially and completely assembled immunoglobulins suggest that thiol-mediated retention does not take place in or beyond the Golgi
39. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic level: Association with NF-kB inhibition
40. Upregulation of intercellular adhesion molecule-1 expression on human endothelial cells by tumor necrosis factor-α in an in vitro model of blood-brain barrier
41. A novel endogenous antimalarial: Fe(II)-protoporphyrin IX α (heme) inhibits hematin polymerization to β-hematin (malaria pigment) and kills malaria parasites
42. Plasmodium falciparum-infected erythrocytes modulate the maturation of dendritic cells
43. A role for CD36 in the regulation of dendritic cell function
44. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine
45. Lung protection by a thiol-containing antioxidant: N-acetylcysteine
46. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure
47. Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: Analysis of the national multicenter study (1976 to 1985)
48. A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV trials network 057 study group
49. Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patient with AIDS
50. The role of oxidative imbalance in progression to AIDS: Effect of thiol supplier N-acetylcysteine
51. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: A prospective controlled trial
52. The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors
53. The surface variant antigens of Plasmodium falciparum contain cross-reactive epitopes
54. Receptor-specific adhesion and clinical disease in Plasmodium falciparum